Hi Matt-
Steatosis is also known as fatty liver; for some reason, GT-3 patients seem to be predisposed to this.
Did you read the link I provided to the Telaprevir studies? That was my take on it; although there may be other info available out there. I’d like to hear a professional interpretation of this for clarity.
Be well--
Bill
what is steatosis?gr8 :(,so geno type 3ers might as well 4get the teleprivar yeah bill?
good luck wit ur prob voisch.
I do know if you have fatty liver it lowers your odds of SVR quite a bit.
If you are currently obese or even overweight, your doctor will probably encourage you to achieve and maintain proper BMI. I don’t know that else they have up their sleeve for managing steatosis, but I believe this is the first line of defense.
I’ve never heard any discussion that links cognitive impairment or disability with hepatic steatosis; this is new to me. Please note that there are no doctors present here; this is a patient to patient forum only.
I’m not sure that the new protease inhibitors will be effective for HCV GT-3; the preliminary data from the Telaprevir trials was less than enthusiastic:
“Conclusions: TVR demonstrated substantial antiviral activity against HCV G2, while its activity against G3 was limited. These findings support additional investigation of TVR for the treatment of G2 HCV infection. “
http://www.natap.org/2009/EASL/EASL_13.htm
Bill
If you are overweight getting down to normal BMI will have and significant effect ive been reading.